Cargando…

Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma

Alternative splicing is an important modification process for the genome to generate mature mRNA by transcription, which has been found associated with survival in some tumors. However, systematic analysis of AS events in pan-renal cell carcinoma at the genome-wide level has been seldom conducted ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Keren, Wu, Yingcheng, Huang, Jing, Wu, Huiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902018/
https://www.ncbi.nlm.nih.gov/pubmed/31850211
http://dx.doi.org/10.3389/fonc.2019.01317
_version_ 1783477606631342080
author Jia, Keren
Wu, Yingcheng
Huang, Jing
Wu, Huiqun
author_facet Jia, Keren
Wu, Yingcheng
Huang, Jing
Wu, Huiqun
author_sort Jia, Keren
collection PubMed
description Alternative splicing is an important modification process for the genome to generate mature mRNA by transcription, which has been found associated with survival in some tumors. However, systematic analysis of AS events in pan-renal cell carcinoma at the genome-wide level has been seldom conducted yet. In the current study, Upset plot and Venn plot were utilized to present the distribution characteristics of AS events. Those SREs were screened out with multivariate COX regression analyses, and functional enrichment analysis was performed to figure out potential pathways. ROC model was conducted to compare the efficiency of those potential SREs. A total of 2,169, 1,671, and 1,414 SREs were found in renal clear cell carcinoma (KIRC), renal chromophobe cell carcinoma (KICH), and renal papillary cell carcinoma (KIRP), respectively. Functional enrichment analysis results suggested possible mechanism such as changes in the branched-chain amino acid catabolic process due to SREs might play a key role in KIRC. The binary logistic regression equation based on the SREs had a good performance in each model compared to the single factor. The 5 year survival model presented that the AUC of the predicted probabilities in KIRC, KICH, and KIRP were 0.754, 1 and 0.841, and in the diagnostic model were 0.988, 0.970, and 0.999, respectively. Some AS types that were significantly different in pan-RCC and paracancerous tissues have also been discovered to play a role in carcinoma screening. To sum up, alternative splicing events significantly interfere with the prognosis of patients with pan-RCC and are capable as biomarkers for prognosis.
format Online
Article
Text
id pubmed-6902018
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69020182019-12-17 Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma Jia, Keren Wu, Yingcheng Huang, Jing Wu, Huiqun Front Oncol Oncology Alternative splicing is an important modification process for the genome to generate mature mRNA by transcription, which has been found associated with survival in some tumors. However, systematic analysis of AS events in pan-renal cell carcinoma at the genome-wide level has been seldom conducted yet. In the current study, Upset plot and Venn plot were utilized to present the distribution characteristics of AS events. Those SREs were screened out with multivariate COX regression analyses, and functional enrichment analysis was performed to figure out potential pathways. ROC model was conducted to compare the efficiency of those potential SREs. A total of 2,169, 1,671, and 1,414 SREs were found in renal clear cell carcinoma (KIRC), renal chromophobe cell carcinoma (KICH), and renal papillary cell carcinoma (KIRP), respectively. Functional enrichment analysis results suggested possible mechanism such as changes in the branched-chain amino acid catabolic process due to SREs might play a key role in KIRC. The binary logistic regression equation based on the SREs had a good performance in each model compared to the single factor. The 5 year survival model presented that the AUC of the predicted probabilities in KIRC, KICH, and KIRP were 0.754, 1 and 0.841, and in the diagnostic model were 0.988, 0.970, and 0.999, respectively. Some AS types that were significantly different in pan-RCC and paracancerous tissues have also been discovered to play a role in carcinoma screening. To sum up, alternative splicing events significantly interfere with the prognosis of patients with pan-RCC and are capable as biomarkers for prognosis. Frontiers Media S.A. 2019-11-27 /pmc/articles/PMC6902018/ /pubmed/31850211 http://dx.doi.org/10.3389/fonc.2019.01317 Text en Copyright © 2019 Jia, Wu, Huang and Wu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Jia, Keren
Wu, Yingcheng
Huang, Jing
Wu, Huiqun
Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
title Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
title_full Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
title_fullStr Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
title_full_unstemmed Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
title_short Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma
title_sort survival-associated alternative splicing events in pan-renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902018/
https://www.ncbi.nlm.nih.gov/pubmed/31850211
http://dx.doi.org/10.3389/fonc.2019.01317
work_keys_str_mv AT jiakeren survivalassociatedalternativesplicingeventsinpanrenalcellcarcinoma
AT wuyingcheng survivalassociatedalternativesplicingeventsinpanrenalcellcarcinoma
AT huangjing survivalassociatedalternativesplicingeventsinpanrenalcellcarcinoma
AT wuhuiqun survivalassociatedalternativesplicingeventsinpanrenalcellcarcinoma